Jazz Pharmaceuticals plc Total Assets
Jazz Pharmaceuticals plc (JAZZ) had Total Assets of $11.08 billion as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-08-03
- 2026-06-30: Assets $11.08B.
- 2026-03-31: Assets $11.86B.
- 2025-12-31: Assets $11.66B; Assets as first filed $11.66B.
- 2025-09-30: Assets $11.36B.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2026-06-30 | $11.08B 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $11.86B 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $11.66B 10-Q · filed 2026-08-03 | $11.66B 10-K · filed 2026-02-24 |
| 2025-09-30 | $11.36B 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $10.94B 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $11.53B 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $12.01B 10-K · filed 2026-02-24 | |
| 2024-09-30 | $12.26B 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $11.36B 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $11.33B 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $11.39B 10-K · filed 2025-02-26 | |
| 2023-09-30 | $11.20B 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $11.26B 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $11.05B 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $10.84B 10-K · filed 2024-02-28 | |
| 2022-09-30 | $10.38B 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $11.20B 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $11.77B 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $12.30B 10-K · filed 2023-03-01 | |
| 2021-09-30 | $12.48B 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $13.21B 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $6.76B 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $6.54B 10-K · filed 2022-03-01 | |
| 2020-09-30 | $6.29B 10-Q · filed 2020-11-02 | |
| 2020-06-30 | $6.07B 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $5.22B 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $5.54B 10-K · filed 2021-02-23 | |
| 2019-09-30 | $5.53B 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $5.49B 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $5.28B 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $5.20B 10-K · filed 2020-02-25 | |
| 2018-09-30 | $5.49B 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $5.35B 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $5.29B 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $5.12B 10-K · filed 2019-02-26 | |
| 2017-09-30 | $5.00B 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $4.80B 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $4.82B 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $4.80B 10-K · filed 2018-02-27 | |
| 2016-09-30 | $4.93B 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $3.45B 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $3.53B 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $3.33B 10-K · filed 2017-02-28 | $3.36B 10-K · filed 2016-02-23 |
| 2015-09-30 | $3.46B 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $3.39B 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $3.24B 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $3.34B 10-K · filed 2016-02-23 | |
| 2014-09-30 | $3.35B 10-Q · filed 2014-11-04 | |
| 2014-06-30 | $3.16B 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $3.20B 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $2.24B 10-K · filed 2015-02-24 | |
| 2013-09-30 | $2.19B 10-Q · filed 2013-11-05 | |
| 2013-06-30 | $2.09B 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $2.01B 10-Q · filed 2013-05-07 | |
| 2012-12-31 | $1.97B 10-K · filed 2014-02-25 | |
| 2012-09-30 | $1.73B 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $1.70B 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $895.36M 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $253.57M 10-K · filed 2013-02-26 | |
| 2011-09-30 | $207.81M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $193.41M 10-Q · filed 2011-08-03 | |
| 2010-12-31 | $135.73M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |